Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor - A population-based case-control study

CONCLUSIONS: Unlike in epithelial ovarian cancer, AGCT development is not clearly associated with parity, and users of postmenopausal HT do not seem to carry an excess risk for AGCT formation.PMID:34598830 | DOI:10.1016/j.ygyno.2021.09.013
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research